Posts

AstraZeneca seals near $1.8B renal disease pact with CSPC

on

PureTech Spins Off Celea with $180M Funding to Advance IPF Drug Deupirfenidone into Phase 3

on

The Francis Crick Institute and Medicines Discovery Catapult Open KQ Labs Applications, Accelerating the Next Wave of Data-Driven Health Innovation

on

New Nature Biotechnology Article Highlights the Need for Cell-Cell Interaction Data in AI Biology

on

Friday Five: Caris Life Sciences hits MCED market

on

Recent US moves add hurdles to US investments in China biotech

on

Production problems hamper Lantheus bid for FDA approval of LNTH-2501 radiopharma diagnostic kit

on

Current status: The Oral GLP-1 Tracker: Lilly takes time to build awareness for Foundayo as generic tirzepatide looms

on

Zymeworks agrees to acquire Theravance Biopharma for $929 million in cash plus contingent consideration

on

Viridian's Lumvoa Gains FDA Nod for Thyroid Eye Disease, Setting Up Clash With Amgen's Tepezza

on

Ipsen acquires Kartos for $1.75B to add Jakafi combo therapy navtemadlin in myelofibrosis

on